Supplemental Figure 1. Melanomas grown in Siah2 -/mice exhibit immune phenotype.
(A) YUMMER1.7 cells (4x10 5 ) were injected into the ank of 5-7 weeks old Siah2 WT or Siah2 -/male mice. H&E staining was performed on tumors collected after 11 days, Scale bar, 100 μm. (B) qPCR analysis of indicated mRNAs was performed on tumors collected 11 days after injection (n=6, both genotypes, Mean ± s.e). (C) YUMMER1.7 cells (10 ) were injected into the ank of 5-7 weeks-old Siah2 WT or Siah2 -/male mice and tumor growth (volume) was assessed over time. N=4 for both genotypes, Mean ± s.e. (D) RNAseq analysis of tumors from both genotypes collected 11 days after melanoma cell injection. Heat map shows all the genes related to the signi cant up/downregulated pathways using the pathway criteria Z-score> 1 and p value < 0.01 (n=5). Siah2 loss in tumor microenvironment increases frequency of intra-tumoral e ector T cells and decreases tumor-in ltrating Tregs.
(A) Weights of tumors from YUMMER1.7 melanoma cell-injected in Siah2 WT or Siah2-/-mice collected 11 days after injection (WT n=4; KO n=5). (B) Quanti cation of CD11B + GR1 + cells on day 11 after tumor injection represented as total number/g tumor tissue or percentage of CD45.2 + immune cells (WT n=4; KO n=5). (C)FOXP3 expression in CD4 + FOXP3 + cells based on ow cytometry (n=6) on day 11 after tumor cells injection. FOXP3 (D) and CD3 (E) staining of tumors from Siah2 WT or Siah2 -/mice, as assessed 11 days after melanoma cells injection (left panels), plus quanti cation (right) (n=3). Scale bar, 100 μm. (F) Percentage of NOS2 + cells among CD11b/F480 + cells on day 11 after tumor cells injection (WT n=4; KO n=5). (G) Weights of tumors from YUMM1.7 cell-injected in Siah2 WT or Siah2 -/mice, collected 11 days after injection (n=5).
(H) Frequencies of tumor-in ltrating IFN γ-producing CD8 + and CD4 + T cells on day 11 after tumor inoculation and following overnight stimulation in vitro with melanoma peptides (n=5) . Frequencies of tumor-in ltrating Foxp3 + CD25 + cells within the CD4 + T cell population (I), CD206 + cells among CD11b/F4/80-positive cells (J), and CD80 + cells among CD11b/F4/80 + and CD11c + MHCII + cells (K) on day 11 after tumor inoculation (n=5). (L) Frequencies of tumor-in ltrating CD45 + among total cells or CD4 + , CD8 + , CD11B + GR1 + and CD11b + /F4/80 + , CD11c + MHCII + cells among CD45 + on day 11 after tumor injection (n=5). Mean ± s.e. Data were analyzed by unpaired t-test. **P < 0.005, *P < 0.05 compared with WT. 
W T S i a h 2 -/ -W T S i a h 2 -/ -W T S i a h 2 -/ -W T S i a h 2 -/ -W T S i a h 2 -/ -

S i a h 2 -/ -S i a h 2 -/ -
Supplementary Figure 5.
Comparable Treg frequency in tumor free WT and Siah2 -/mice; comparable treg suppression function in vitro in Siah2 -/and WT treg. (A) Draining lymph nodes from Siah2 WT and Siah2 -/mice were collected and the percentage of CD4 + and CD8 + cells among CD45.2 + cells, plus the percentage of Foxp3 + cells in CD4 + cells were determined by ow cytometry (WT n=8; Siah2 -/-n=11). (B)Lymphocytes were cultured and stimulated with CD3/CD28 antibodies in presence of IL2, and 3 days later assessed for Ki67 expression in CD8 + , CD4 + Foxp3 -, CD4 + Foxp3 + cells based on ow cytometry (n=4). (C) Lysates made from unstimulated lymphocytes derived from draining Lymph nodes were prepared and immunoblotted for p27 and GAPDH (n=4). (D) q-RTPCR analysis of p27 mRNA from lymphocytes stimulated as in panel B. n=4, both genotypes. (E) In vitro suppression assay of conventional CD4 + T cells (Tconv.) labeled with cytosolic dye carboxy uorescein diacetate succinimidyl ester (CFSE) in the presence of WT or Siah2 -/-Treg cells (CD4 + CD25 + ) and quanti cation (right panel). Numbers indicate the percentage of cells in the indicated area. Conventional CD4 + T cell division was analyzed by CFSE dilution at the indicated ratios of Tconv and Treg cells following 3 day stimulation with plate bound anti-CD3 andanti-CD28 (both 2ug/mL). Graph on the right panel is the average percent inhibition (100 -% divided) of three individual experiments ( ve biological replicates) of WT versus Siah2 -/-Treg cells. (F) Frequencies of tumor-in ltrating TGFβ + or IL10 + CD4 + /CD25 + T cells 11 days after tumor cells inoculation and following overnight stimulation in vitro with PMA and Ionomicin (n=5). (G) Left two panels:Percentage of CCR8 + and CXCR3 + cells among CD4/CD25 + cells on day 11 after tumor cells injection (n=5 for CCR8 + and n=4 for CXCR3 + cells ), right panel: qPCR analysis of Ccl1 mRNA was performed on tumors collected 11 days after injection (n=5, both genotypes, Mean ± s.e). Frequencies of Foxp3 + cells within the CD4 population from the lymph nodes (H) and spleen (I) of tumor-free mice (n=5). (J) Frequencies of CD4/CD8 double negative, CD4/CD8 double-positive, and single-positive CD4 or CD8 cells from thymus of Siah2 WT and Siah2 -/mice (n=5). Frequencies of Foxp3-positive cells in the CD4 population (K) and GITR + CD25 + in the CD4 + Foxp3population (L) from thymus of Siah2 WT and Siah2 -/mice (n=5). Mean ± s.e. Data were analyzed by unpaired t-test. ***P < 0.0005, **P < 0.005, *P < 0.05 compared with WT. A and B, growth inhibition upon Siah2 deletion is p27 dependent. q-RTPCR analysis of Siah2 (A) and p27 (B) mRNA from Jurkat cells depleted of Siah2 and p27 after infection with shRNA encoding lentiviruses. Mean ± s.e., n=4. C and D, growth inhibition upon Siah2 deletion in Treg cells is p27 dependent: q-RTPCR analysis of p27 (C) and Ki67 (D) mRNA from isolated WT or Siah2 -/-Treg cells in which p27 was knocked down after infection with shRNA encoding lentiviruses. Mean ± s.e., n=3. E, individual (J) tumor growth curves over time of YUMM1.7 cells (150,000) inoculated in WT and Siah2 -/mice and treated with anti-PD1 antibody. Mice were treated with either rat isotype (IgG) or anti-PD1 antibody (200 μg/ mouse; 3 times per week for a total of 5 times) starting from day 7 after melanoma cells injection. WT and Siah2 -/-IgG (n=8); WT and Siah2-/-anti-PD1 (n=7). Complete regression (CR) rates at study termination are shown (J). F, MC38 cells (500,000) were inoculated in WT (n=8) and Siah2 -/-(n=7) mice. Seven days later, mice were subjected to administration of anti-PD1 antibody(100 μg/ mouse) or rat isotype (IgG) 3 times per week, for total of 4 injections. Mean ± s.e. data were analyzed by unpaired t-test (A-D) or two-way ANOVA with Bonferroni multiple comparison (F). ***P < 0.0005, **P < 0.005, *P < 0.05 compared to Scr control. shRNA (A, C, D), Siah2#1 shRNA (B), WT + anti-PD1 (F). G, Correlation of Siah2 and Foxp3 expression in high immunogenic human melanoma specimens; Shown are Spearman's rank correlations that are indicated for each gene (R and P values). 
